Literature DB >> 15068200

HIV prevention nongovernmental organizations in Central and Eastern Europe: programs, resources and challenges.

Y A Amirkhanian1, J A Kelly, E G Benotsch, A M Somlai, K D Brown, M I Fernandez, K M Opgenorth.   

Abstract

HIV incidence is rising more rapidly in some areas of Central and Eastern Europe than anywhere else in the world. Carrying out effective HIV prevention programs requires the presence of "bridges" that can reach community populations most vulnerable to the disease. Nongovernmental organizations (NGOs) are in a natural role to conduct HIV prevention programs. The Directors of 29 HIV prevention NGOs representing almost all countries in Central and Eastern Europe participated in in-depth interviews by telephone. The broad topics of these interviews included descriptions of the three largest programs conducted by each NGO during the past six months, at-risk target populations served, major barriers faced, and funding sources that sponsored HIV prevention activities. NGO programs most often targeted injection drug users (IDUs); other stigmatized groups were less frequently served by NGOs in the sample. The most common types of prevention activities were needle exchange, HIV prevention peer education, and delivering AIDS presentations and distributing educational materials. Among the major barriers that hampered effective conduct of HIV prevention programs were a shortage of available financial resources, governmental indifference or opposition, and AIDS-related stigma. National governments rarely provided substantial funds for NGO programs, and most funding came from United Nations agencies or private foundations. The information sources reported to be most helpful in assisting NGOs in program development were sharing ideas with other NGOs, participating in conferences, and accessing information from the Internet. A number of programs reported by the NGO Directors were innovative, outstanding, and comprehensive. Five such exemplary programs are described in this article. HIV epidemics in the region are still potentially controllable. NGOs need immediate support so that they can carry out their community-based activities on a larger scale.

Entities:  

Mesh:

Year:  2004        PMID: 15068200

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  7 in total

Review 1.  Review of HIV vulnerability and condom use in central and eastern Europe.

Authors:  Yuri A Amirkhanian
Journal:  Sex Health       Date:  2012-03       Impact factor: 2.706

2.  HIV risk behavior in male and female Russian sexually transmitted disease clinic patients.

Authors:  Eric G Benotsch; Steven D Pinkerton; Roman V Dyatlov; Wayne DiFranceisco; Tatyana S Smirnova; Valentina Y Dudko; Andrei Kozlov
Journal:  Int J Behav Med       Date:  2006

3.  Emerging opportunities and challenges for HIV prevention, treatment and care for MSM in the former Soviet Union and other post-communist states in Eastern Europe.

Authors:  Yuri A Amirkhanian
Journal:  Sex Transm Infect       Date:  2017-04-07       Impact factor: 3.519

4.  Law enforcement practices associated with HIV infection among injection drug users in Odessa, Ukraine.

Authors:  Robert E Booth; Sergey Dvoryak; Min Sung-Joon; John T Brewster; William W Wendt; Karen F Corsi; Oleg Y Semerik; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2013-10

5.  Activism, NGOs, and HIV Prevention in Postsocialist Poland: The Role of "Anti-Politics"

Authors:  Jill Owczarzak
Journal:  Hum Organ       Date:  2010

6.  Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.

Authors:  Han-Zhu Qian; Joseph E Schumacher; Huey T Chen; Yu-Hua Ruan
Journal:  Harm Reduct J       Date:  2006-02-01

Review 7.  Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review.

Authors:  Arman Sanadgol; Leila Doshmangir; Reza Majdzadeh; Vladimir Sergeevich Gordeev
Journal:  Global Health       Date:  2021-11-16       Impact factor: 4.185

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.